ANG Lifesciences India Limited reported its financial results for the year ended March 31, 2026. The company’s total income stood at ₹9,233.11 lakhs, with operating expenses amounting to ₹8,499.18 lakhs. The standalone financial statements indicate a profit before tax of ₹(519.09) lakhs and a net loss for the year after tax of ₹(472.64) lakhs. The consolidated financial statements show a total income of ₹9,486.62 lakhs and a consolidated loss for the year of ₹(1,241.33) lakhs.
Financial Performance Overview
ANG Lifesciences India Limited has released its financial results for the fiscal year ended March 31, 2026. The company reported a total income of ₹9,233.11 lakhs on a standalone basis, compared to ₹9,235.41 lakhs in the previous year. However, operating expenses also increased, leading to a profit before tax of ₹(519.09) lakhs. The net loss for the year after tax was ₹(472.64) lakhs.
Consolidated Financials
On a consolidated basis, the Group’s total income was ₹9,486.62 lakhs. The consolidated profit before tax stood at ₹(1,301.07) lakhs, resulting in a consolidated loss for the year after tax of ₹(1,108.49) lakhs. The consolidated statement of profit and loss reflects a total comprehensive income loss of ₹(1,101.33) lakhs.
Key Financial Ratios
The company’s financial ratios indicate a current ratio of 1.07 for FY26, down from 1.17 in FY25. The debt-equity ratio was 1.04, showing a slight increase from 1.01. The net profit ratio for FY26 was -0.05%, an improvement from -0.12% in the previous year, reflecting a reduced net loss. The report also details various other financial ratios including inventory turnover, trade receivables turnover, and return on capital employed.
Segmental Performance
The company operates in two reportable segments: Pharmaceuticals and Packaging and printing. The Pharmaceuticals segment generated revenue of ₹9,160.45 lakhs in FY26, with a segment profit before tax of ₹(519.12) lakhs. The Packaging and printing segment reported revenues of ₹486.22 lakhs and a segment profit before tax of ₹(781.95) lakhs. Total segment assets for Pharmaceuticals were ₹18,991.17 lakhs, while for Packaging and printing they were ₹2,988.28 lakhs.
Source: BSE
